+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Companion Diagnostic Market By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others), By Products, By Indication, By End-User, By Application, By Region, Competition, Forecast & Opportunities, 2025

  • ID: 5031335
  • Report
  • May 2020
  • Region: Global
  • TechSci Research
The Global Companion Diagnostic Market Size Was Valued at Usd3 Billion in 2019 and Projected to Grow at An Impressive CAGR During the Forecast Period.

FEATURED COMPANIES

  • Abbott
  • Biomerieux SA
  • Genentech
  • Luminex Corporation
  • NG Biotech
  • Perkin Elmer
  • MORE
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Companion Diagnostic Market size was valued at USD3 billion in 2019 and projected to grow at an impressive CAGR during the forecast period. The key factor responsible for the growth of the companion diagnostic market is growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of the companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2025.

The Global Companion Diagnostic Market is segmented based on technology, products, indication, end-user, application, and region. Based on end-user, the market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization and others. Out of which, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to widespread use of companion diagnostics in such industries because of their increasing stronghold in the drug development sector as well as growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with the high demand for targeted therapies for treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the Global Companion Diagnostic Market include NG Biotech, Agilent Technologies, Illumnia, Qiagen, Thermo Fisher Scientific, Roche, Molecular MD, Myriad Genetics, Foundation Medicine, Bayer, Genentech, Abbott, Novartis, Perkin Elmer, Luminex Corporation, Parexel, Quest Diagnostics, Genesys Diagnostics, Danaher, Siemens Healthcare, Biomerieux SA and others. The companies operating in the Global Companion Diagnostic Market are focussing towards expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyse and forecast the market size of the Global Companion Diagnostic Market.
  • To classify and forecast the Global Companion Diagnostic Market based on technology, products, indication, end-user, application, company and regional distribution.
  • To identify drivers and challenges for the Global Companion Diagnostic Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Companion Diagnostic Market.
  • To conduct pricing analysis for the Global Companion Diagnostic Market.
  • To identify and analyse the profile of leading players operating in the Global Companion Diagnostic Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals/clinics across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The author analyzed the new products, technologies and presence of all major players across the globe.

The author calculated the market size of the Global Companion Diagnostic Market by using a bottom-up approach, wherein the data for various end-user segments was recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Companion Diagnostic Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Technology:
  • Nanostring Technology
  • Next-Generation sequencing
  • In-Situ Hybridization
  • Immunohistochemistry
  • Others
Market, By Products:
  • Devices
  • Kits
  • Assay
Market, By Indication:
  • Oncology
  • Respiratory
  • Orthopedics
  • Others
Market, By End-User:
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories
  • Contract research organization
  • Others
Market, By Application:
  • Drug Discovery
  • In-Vitro diagnostics
  • Others
Market, By Region:
  • North America
  • United States
  • Mexico
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Companion Diagnostic Market.

Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.

Please note: With the Enterprise license, the PDF product is printable and editable and comes with a market data excel sheet.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Biomerieux SA
  • Genentech
  • Luminex Corporation
  • NG Biotech
  • Perkin Elmer
  • MORE
1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Companion Diagnostic Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value & Volume
4.2. Market Share & Forecast
4.2.1. By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others)
4.2.2. By Products (Devices, Kits and assay)
4.2.3. By Indication (Oncology, Respiratory, Orthopedics and Others)
4.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract research organization and others)
4.2.5. By Application (Drug Discovery, In-Vitro diagnostics and Others)
4.2.6. By Company (2019)
4.2.7. By Region
4.3. Market Attractiveness Index

5. Asia-Pacific Companion Diagnostic Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Products
5.2.3. By Indication
5.2.4. By End-User
5.2.5. By Application
5.2.6. By Country
5.3. Market Attractiveness Index
5.4. Asia-Pacific: Country Analysis
5.4.1. China Companion Diagnostic Market Outlook
5.4.1.1. Market Size & Forecast
5.4.1.1.1. By Value
5.4.1.2. Market Share & Forecast
5.4.1.2.1. By Technology
5.4.1.2.2. By Products
5.4.1.2.3. By Indication
5.4.1.2.4. By End-User
5.4.1.2.5. By Application
5.4.2. India Companion Diagnostic Market Outlook
5.4.2.1. Market Size & Forecast
5.4.2.1.1. By Value
5.4.2.2. Market Share & Forecast
5.4.2.2.1. By Technology
5.4.2.2.2. By Products
5.4.2.2.3. By Indication
5.4.2.2.4. By End-User
5.4.2.2.5. By Application
5.4.3. Japan Companion Diagnostic Market Outlook
5.4.3.1. Market Size & Forecast
5.4.3.1.1. By Value
5.4.3.2. Market Share & Forecast
5.4.3.2.1. By Technology
5.4.3.2.2. By Products
5.4.3.2.3. By Indication
5.4.3.2.4. By End-User
5.4.3.2.5. By Application
5.4.4. South Korea Companion Diagnostic Market Outlook
5.4.4.1. Market Size & Forecast
5.4.4.1.1. By Value
5.4.4.2. Market Share & Forecast
5.4.4.2.1. By Technology
5.4.4.2.2. By Products
5.4.4.2.3. By Indication
5.4.4.2.4. By End-User
5.4.4.2.5. By Application
5.4.5. Singapore Companion Diagnostic Market Outlook
5.4.5.1. Market Size & Forecast
5.4.5.1.1. By Value
5.4.5.2. Market Share & Forecast
5.4.5.2.1. By Technology
5.4.5.2.2. By Products
5.4.5.2.3. By Indication
5.4.5.2.4. By End-User
5.4.5.2.5. By Application
5.4.6. Australia Companion Diagnostic Market Outlook
5.4.6.1. Market Size & Forecast
5.4.6.1.1. By Value
5.4.6.2. Market Share & Forecast
5.4.6.2.1. By Technology
5.4.6.2.2. By Products
5.4.6.2.3. By Indication
5.4.6.2.4. By End-User
5.4.6.2.5. By Application

6. Europe Companion Diagnostic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Products
6.2.3. By Indication
6.2.4. By End-User
6.2.5. By Application
6.2.6. By Country
6.3. Market Attractiveness Index
6.4. Europe: Country Analysis
6.4.1. France Companion Diagnostic Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Technology
6.4.1.2.2. By Products
6.4.1.2.3. By Indication
6.4.1.2.4. By End-User
6.4.1.2.5. By Application
6.4.2. Germany Companion Diagnostic Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Technology
6.4.2.2.2. By Products
6.4.2.2.3. By Indication
6.4.2.2.4. By End-User
6.4.2.2.5. By Application
6.4.3. United Kingdom Companion Diagnostic Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Technology
6.4.3.2.2. By Products
6.4.3.2.3. By Indication
6.4.3.2.4. By End-User
6.4.3.2.5. By Application
6.4.4. Italy Companion Diagnostic Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Technology
6.4.4.2.2. By Products
6.4.4.2.3. By Indication
6.4.4.2.4. By End-User
6.4.4.2.5. By Application

7. North America Companion Diagnostic Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Products
7.2.3. By Indication
7.2.4. By End-User
7.2.5. By Application
7.2.6. By Country
7.3. Market Attractiveness Index
7.4. North America: Country Analysis
7.4.1. United States Companion Diagnostic Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Technology
7.4.1.2.2. By Products
7.4.1.2.3. By Indication
7.4.1.2.4. By End-User
7.4.1.2.5. By Application
7.4.2. Mexico Companion Diagnostic Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Technology
7.4.2.2.2. By Products
7.4.2.2.3. By Indication
7.4.2.2.4. By End-User
7.4.2.2.5. By Application
7.4.3. Canada Companion Diagnostic Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Technology
7.4.3.2.2. By Products
7.4.3.2.3. By Indication
7.4.3.2.4. By End-User
7.4.3.2.5. By Application

8. South America Companion Diagnostic Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Products
8.2.3. By Indication
8.2.4. By End-User
8.2.5. By Application
8.2.6. By Country
8.3. Market Attractiveness Index
8.4. South America: Country Analysis
8.4.1. Brazil Companion Diagnostic Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Technology
8.4.1.2.2. By Products
8.4.1.2.3. By Indication
8.4.1.2.4. By End-User
8.4.1.2.5. By Application
8.4.2. Argentina Companion Diagnostic Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Technology
8.4.2.2.2. By Products
8.4.2.2.3. By Indication
8.4.2.2.4. By End-User
8.4.2.2.5. By Application
8.4.3. Colombia Companion Diagnostic Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Technology
8.4.3.2.2. By Products
8.4.3.2.3. By Indication
8.4.3.2.4. By End-User
8.4.3.2.5. By Application

9. Middle East and Africa Companion Diagnostic Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Products
9.2.3. By Indication
9.2.4. By End-User
9.2.5. By Application
9.2.6. By Country
9.3. Market Attractiveness Index
9.4. MEA: Country Analysis
9.4.1. South Africa Companion Diagnostic Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Technology
9.4.1.2.2. By Products
9.4.1.2.3. By Indication
9.4.1.2.4. By End-User
9.4.1.2.5. By Application
9.4.2. Saudi Arabia Companion Diagnostic Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Technology
9.4.2.2.2. By Products
9.4.2.2.3. By Indication
9.4.2.2.4. By End-User
9.4.2.2.5. By Application
9.4.3. UAE Companion Diagnostic Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Technology
9.4.3.2.2. By Products
9.4.3.2.3. By Indication
9.4.3.2.4. By End-User
9.4.3.2.5. By Application

10. Market Dynamics
10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape
12.1. Competition Outlook
12.2. Players Profiled (Leading Companies)
12.2.1. NG Biotech
12.2.2. Agilent Technologies
12.2.3. Illumnia
12.2.4. Qiagen
12.2.5. Thermo Fisher Scientific
12.2.6. Roche
12.2.7. Molecular MD
12.2.8. Myriad Genetics
12.2.9. Foundation Medicine
12.2.10. Bayer
12.2.11. Genentech
12.2.12. Abbott
12.2.13. Novartis
12.2.14. Perkin Elmer
12.2.15. Luminex Corporation
12.2.16. Parexel
12.2.17. Quest Diagnostics
12.2.18. Genesys Diagnostics
12.2.19. Danaher
12.2.20. Siemens Healthcare
12.2.21. Biomerieux SA

13. Strategic Recommendations

14. About the author & Disclaimer
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • NG Biotech
  • Agilent Technologies
  • Illumnia
  • Qiagen
  • Thermo Fisher Scientific
  • Roche
  • Molecular MD
  • Myriad Genetics
  • Foundation Medicine
  • Bayer
  • Genentech
  • Abbott
  • Novartis
  • Perkin Elmer
  • Luminex Corporation
  • Parexel
  • Quest Diagnostics
  • Genesys Diagnostics
  • Danaher
  • Siemens Healthcare
  • Biomerieux SA
Note: Product cover images may vary from those shown
Adroll
adroll